King® Guide to Parenteral Admixtures®

Online Edition

Welcome to the King Guide to Parenteral Admixtures Internet Edition.

Enter Login Information



Now Available!
COVID-19 Vaccine Product & Stability Information

License Agreement


Winter 2021

In this update we added new monographs for ATEZOLIZUMAB and TRILACICLIB.

We also added new stability information to COVID-19 VACCINE, mRNA, and to 48 other existing drug monographs.

New compatibility information was added to these existing drug monographs: CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, FOSPHENYTOIN, LEVETIRACETAM, NALOXONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, PROPOFOL, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.

  © 2021 - King Guide Publications, Inc. All rights reserved.